naltrexone has been researched along with Diabetic Neuropathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, D; Bhansali, AK; Chakrabarti, A; Dutta, P; Hota, D; Srinivasan, A | 1 |
| Castañeda-Hernández, G; Chávez-Piña, AE; Landa-Juárez, AY; Ortiz, MI; Pérez-Severiano, F | 1 |
| Baumrucker, SJ; Trofimovitch, D | 1 |
| Bhansali, A; Chakrabarti, A; Dutta, P; Hota, D; Srinivasan, A | 1 |
| Kamei, J; Kasuya, Y; Saitoh, A | 1 |
| Crain, SM | 1 |
1 review(s) available for naltrexone and Diabetic Neuropathies
| Article | Year |
|---|---|
Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes.
Topics: Analgesics, Non-Narcotic; Cancer Pain; Chronic Pain; Complex Regional Pain Syndromes; Diabetic Neuropathies; Dose-Response Relationship, Drug; Fibromyalgia; Humans; Naltrexone; Pain Management; Palliative Care; Quality of Life | 2019 |
1 trial(s) available for naltrexone and Diabetic Neuropathies
| Article | Year |
|---|---|
Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial.
Topics: Amitriptyline; Analgesics, Non-Narcotic; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Pain; Pain Measurement | 2021 |
4 other study(ies) available for naltrexone and Diabetic Neuropathies
| Article | Year |
|---|---|
The antihyperalgesic effect of docosahexaenoic acid in streptozotocin-induced neuropathic pain in the rat involves the opioidergic system.
Topics: Analgesics; Analgesics, Opioid; Animals; Diabetic Neuropathies; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Gabapentin; Naloxone; Naltrexone; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Receptors, sigma; Streptozocin | 2019 |
Off-Label, Low-Dose Naltrexone for Refractory Painful Diabetic Neuropathy.
Topics: Aged; Diabetic Neuropathies; Humans; Male; Naltrexone; Narcotic Antagonists; Pain, Intractable | 2016 |
Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice.
Topics: Animals; Diabetic Neuropathies; Male; Mexiletine; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reference Values | 1995 |
Neurotrophic factors in diabetic neuropathy.
Topics: Animals; Cells, Cultured; Diabetic Neuropathies; Ganglia, Spinal; Naloxone; Naltrexone; Nerve Growth Factors; Paclitaxel | 1995 |